253 related articles for article (PubMed ID: 30668977)
1. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
[TBL] [Abstract][Full Text] [Related]
2. Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.
Brouillette RB; Phillips EK; Ayithan N; Maury W
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100617
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
4. Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus.
Pan X; Wu Y; Wang W; Zhang L; Xiao G
Antiviral Res; 2020 Feb; 174():104666. PubMed ID: 31760108
[TBL] [Abstract][Full Text] [Related]
5. Guinea Pig Transferrin Receptor 1 Mediates Cellular Entry of Junín Virus and Other Pathogenic New World Arenaviruses.
Hickerson BT; Westover JB; Wang Z; Lee YM; Gowen BB
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748396
[TBL] [Abstract][Full Text] [Related]
6. Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs.
López N; Scolaro L; Rossi C; Jácamo R; Candurra N; Pujol C; Damonte EB; Franze-Fernández MT
J Gen Virol; 2000 May; 81(Pt 5):1273-81. PubMed ID: 10769070
[TBL] [Abstract][Full Text] [Related]
7. Glycoprotein N-linked glycans play a critical role in arenavirus pathogenicity.
Koma T; Huang C; Coscia A; Hallam S; Manning JT; Maruyama J; Walker AG; Miller M; Smith JN; Patterson M; Abraham J; Paessler S
PLoS Pathog; 2021 Mar; 17(3):e1009356. PubMed ID: 33647064
[TBL] [Abstract][Full Text] [Related]
8. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
[TBL] [Abstract][Full Text] [Related]
9. Contrasting Modes of New World Arenavirus Neutralization by Immunization-Elicited Monoclonal Antibodies.
Ng WM; Sahin M; Krumm SA; Seow J; Zeltina A; Harlos K; Paesen GC; Pinschewer DD; Doores KJ; Bowden TA
mBio; 2022 Apr; 13(2):e0265021. PubMed ID: 35315691
[TBL] [Abstract][Full Text] [Related]
10. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Innate Immune Responses to Pathogenic and Nonpathogenic Clade B New World Arenaviruses.
Moreno H; Möller R; Fedeli C; Gerold G; Kunz S
J Virol; 2019 Oct; 93(19):. PubMed ID: 31270228
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Antibodies with Neutralizing Activity and Fc-Effector Functions against the Machupo Virus Glycoprotein.
Amanat F; Duehr J; Huang C; Paessler S; Tan GS; Krammer F
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801871
[TBL] [Abstract][Full Text] [Related]
13. A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.
Ziegler CM; Eisenhauer P; Kelly JA; Dang LN; Beganovic V; Bruce EA; King BR; Shirley DJ; Weir ME; Ballif BA; Botten J
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187543
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.
Clark LE; Mahmutovic S; Raymond DD; Dilanyan T; Koma T; Manning JT; Shankar S; Levis SC; Briggiler AM; Enria DA; Wucherpfennig KW; Paessler S; Abraham J
Nat Commun; 2018 May; 9(1):1884. PubMed ID: 29760382
[TBL] [Abstract][Full Text] [Related]
15. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
16. Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector.
Johnson DM; Jokinen JD; Wang M; Pfeffer T; Tretyakova I; Carrion R; Griffiths A; Pushko P; Lukashevich IS
Vaccine; 2020 Mar; 38(14):2949-2959. PubMed ID: 32111526
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of Junín virus by single domain antibodies targeted against the nucleoprotein.
Linero F; Sepúlveda C; Christopoulou I; Hulpiau P; Scolaro L; Saelens X
Sci Rep; 2018 Jul; 8(1):11451. PubMed ID: 30061671
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.
Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F
mSphere; 2018; 3(3):. PubMed ID: 29720525
[TBL] [Abstract][Full Text] [Related]
19. Description and characterization of a novel live-attenuated tri-segmented Machupo virus in Guinea pigs.
Zaza AD; Herbreteau CH; Peyrefitte CN
Virol J; 2018 Jun; 15(1):99. PubMed ID: 29879985
[TBL] [Abstract][Full Text] [Related]
20. Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses.
Nakauchi M; Fukushi S; Saijo M; Mizutani T; Ure AE; Romanowski V; Kurane I; Morikawa S
Clin Vaccine Immunol; 2009 Aug; 16(8):1132-8. PubMed ID: 19553554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
